← FDA Drug Approvals (Drugs@FDA)
DIAZEPAM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS ISRAEL PHARMA LTD · Approved 2025-11-12
Drug application
- FDA Application #
ANDA219320
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DIAZEPAM
- Generic name
- Diazepam
- Active ingredients
- DIAZEPAM
- Dosage form
- Spray
- Route
- —
- Marketing status
- None (Tentative Approval)
- Sponsor
- PADAGIS ISRAEL PHARMA LTD
- First approval
- 2025-11-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown